• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在实验室动物模型中选择高脂肪、高果糖和高胆固醇饮食以诱导实验性非酒精性脂肪性肝病时的注意事项

Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models.

作者信息

Radhakrishnan Sridhar, Yeung Steven F, Ke Jia-Yu, Antunes Maísa M, Pellizzon Michael A

机构信息

Research Diets, Inc., New Brunswick, NJ, USA.

Center for Gastrointestinal Biology, Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.

出版信息

Curr Dev Nutr. 2021 Nov 13;5(12):nzab138. doi: 10.1093/cdn/nzab138. eCollection 2021 Dec.

DOI:10.1093/cdn/nzab138
PMID:34993389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8718327/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is intricately linked to metabolic disease (including obesity, glucose intolerance, and insulin resistance) and encompasses a spectrum of disorders including steatosis, nonalcoholic steatohepatitis (NASH), and fibrosis. Rodents consuming high-fat (HF; ∼40 kcal% fat including fats containing higher concentrations of saturated and fats), high-fructose (HFr), and high-cholesterol (HC) diets display many clinically relevant characteristics of NASH, along with other metabolic disorders. C57BL/6 mice are the most commonly used animal model because they can develop significant metabolic disorders including severe NASH with fibrosis after months of feeding, but other models also are susceptible. The significant number of diets that contain these different factors (i.e., HF, HFr, and HC), either alone or in combination, makes the choice of diet difficult. This methodology review describes the efficacy of these nutrient manipulations on the NAFLD phenotype in mice, rats, guinea pigs, hamsters, and nonhuman primates.

摘要

非酒精性脂肪性肝病(NAFLD)与代谢性疾病(包括肥胖、葡萄糖不耐受和胰岛素抵抗)有着复杂的联系,涵盖了一系列疾病,包括脂肪变性、非酒精性脂肪性肝炎(NASH)和肝纤维化。食用高脂肪(HF;约40千卡%脂肪,包括含有较高浓度饱和脂肪和不饱和脂肪的脂肪)、高果糖(HFr)和高胆固醇(HC)饮食的啮齿动物表现出许多与NASH临床相关的特征,以及其他代谢紊乱。C57BL/6小鼠是最常用的动物模型,因为它们在喂食数月后会出现严重的代谢紊乱,包括伴有肝纤维化的严重NASH,但其他模型也易受影响。含有这些不同因素(即HF、HFr和HC)的大量饮食,无论是单独还是组合使用,都使得饮食选择变得困难。本方法学综述描述了这些营养干预对小鼠、大鼠、豚鼠、仓鼠和非人灵长类动物NAFLD表型的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02e/8718327/e2a3a6cd8e1a/nzab138fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02e/8718327/e2a3a6cd8e1a/nzab138fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02e/8718327/e2a3a6cd8e1a/nzab138fig1.jpg

相似文献

1
Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models.在实验室动物模型中选择高脂肪、高果糖和高胆固醇饮食以诱导实验性非酒精性脂肪性肝病时的注意事项
Curr Dev Nutr. 2021 Nov 13;5(12):nzab138. doi: 10.1093/cdn/nzab138. eCollection 2021 Dec.
2
Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.高脂、高果糖、高胆固醇饮食喂养的叙利亚仓鼠血脂异常和非酒精性脂肪性肝病(NAFLD)的时间发展情况。
Nutrients. 2021 Feb 12;13(2):604. doi: 10.3390/nu13020604.
3
Hepatic adverse effects of fructose consumption independent of overweight/obesity.果糖摄入与超重/肥胖无关的肝脏不良影响。
Int J Mol Sci. 2013 Nov 5;14(11):21873-86. doi: 10.3390/ijms141121873.
4
[Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].[高脂/高果糖饮食诱导的非酒精性脂肪性肝炎小鼠模型的建立与评价]
Zhonghua Gan Zang Bing Za Zhi. 2014 Jun;22(6):445-50. doi: 10.3760/cma.j.issn.1007-3418.2014.06.010.
5
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.快餐饮食诱导的肥胖小鼠:一种新型的非酒精性脂肪性肝炎(NASH)小动物模型,具有气球样变、进行性纤维化的特征,并且在很大程度上模拟了人类的生理状态。
Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G825-34. doi: 10.1152/ajpgi.00145.2011. Epub 2011 Aug 11.
6
Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.饱和脂肪和胆固醇对于引发伴有严重非酒精性脂肪性肝炎的小鼠代谢综合征至关重要。
J Nutr Biochem. 2015 Mar;26(3):285-92. doi: 10.1016/j.jnutbio.2014.11.002. Epub 2014 Dec 6.
7
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.美国生活方式引起的肥胖综合征饮食在雄性和雌性啮齿动物中再现了非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G345-G360. doi: 10.1152/ajpgi.00055.2020. Epub 2020 Aug 5.
8
High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.高果糖、中链反式脂肪饮食诱导肥胖和非酒精性脂肪性肝炎新型小鼠模型肝纤维化和血浆辅酶 Q9 升高。
Hepatology. 2010 Sep;52(3):934-44. doi: 10.1002/hep.23797.
9
The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.FATZO小鼠是2型糖尿病的下一代模型,在喂食添加了果糖的西式饮食时会发展为非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)。
BMC Gastroenterol. 2019 Mar 18;19(1):41. doi: 10.1186/s12876-019-0958-4.
10
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.膳食胆固醇和膳食脂肪在诱导实验性脂肪性肝炎中的协同作用。
Hepatology. 2013 Jan;57(1):81-92. doi: 10.1002/hep.25789.

引用本文的文献

1
Advancing hepatotoxicity assessment: current advances and future directions.推进肝毒性评估:当前进展与未来方向
Toxicol Res. 2025 Apr 24;41(4):303-323. doi: 10.1007/s43188-025-00289-w. eCollection 2025 Jul.
2
Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review.代谢功能障碍相关脂肪性肝病(MASLD)中果糖摄入的致病因素:一篇叙述性综述
Cell Stress. 2025 Jun 24;9:49-64. doi: 10.15698/cst2025.06.305. eCollection 2025.
3
Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice.

本文引用的文献

1
Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity.罗格列酮需要肝细胞 PPARγ 表达来促进饮食诱导肥胖雄性小鼠的脂肪变性。
Endocrinology. 2021 Nov 1;162(11). doi: 10.1210/endocr/bqab175.
2
Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.高脂、高果糖、高胆固醇饮食喂养的叙利亚仓鼠血脂异常和非酒精性脂肪性肝病(NAFLD)的时间发展情况。
Nutrients. 2021 Feb 12;13(2):604. doi: 10.3390/nu13020604.
3
Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis.
基于油酰乙醇胺的膳食补充剂对饮食诱导的小鼠肥胖的肝脏保护和抗动脉粥样硬化作用
Pathophysiology. 2025 Apr 18;32(2):16. doi: 10.3390/pathophysiology32020016.
4
Asprosin-FABP5 Interaction Modulates Mitochondrial Fatty Acid Oxidation through PPARα Contributing to MASLD Development.血管生成素与脂肪酸结合蛋白5的相互作用通过过氧化物酶体增殖物激活受体α调节线粒体脂肪酸氧化,促进代谢相关脂肪性肝病的发展。
Adv Sci (Weinh). 2025 Jun;12(21):e2415846. doi: 10.1002/advs.202415846. Epub 2025 Apr 15.
5
The evolution of steatosis and fibrosis in mice on a MASH-inducing diet and the effects of housing temperature.采用致MASH饮食的小鼠脂肪变性和纤维化的演变及饲养温度的影响
Am J Physiol Endocrinol Metab. 2025 Apr 1;328(4):E513-E523. doi: 10.1152/ajpendo.00401.2024. Epub 2025 Feb 25.
6
ZDY2013 Inhibits the Development of Non-Alcoholic Fatty Liver Disease by Regulating the Intestinal Microbiota and Modulating the PI3K/Akt Pathway.ZDY2013 通过调节肠道微生物群和调节 PI3K/Akt 通路抑制非酒精性脂肪性肝病的发展。
Nutrients. 2024 Mar 27;16(7):958. doi: 10.3390/nu16070958.
7
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model.混合谱系激酶结构域样蛋白在饮食诱导的肥胖、肝脏病理及胰岛素敏感性中的非坏死性作用:来自高脂、高果糖、高胆固醇饮食小鼠模型的见解
Int J Mol Sci. 2024 Feb 28;25(5):2813. doi: 10.3390/ijms25052813.
8
Early transcriptome changes associated with western diet induced NASH in mice points to activation of hepatic macrophages and an acute phase response.与西方饮食诱导的小鼠非酒精性脂肪性肝炎相关的早期转录组变化表明肝巨噬细胞的激活和急性期反应。
Front Nutr. 2023 Aug 7;10:1147602. doi: 10.3389/fnut.2023.1147602. eCollection 2023.
9
In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations.在体和体外模型研究肝纤维化:机制和局限性。
Cell Mol Gastroenterol Hepatol. 2023;16(3):355-367. doi: 10.1016/j.jcmgh.2023.05.010. Epub 2023 Jun 1.
10
Hepatic transcriptome profiling reveals early signatures associated with disease transition from non-alcoholic steatosis to steatohepatitis.肝脏转录组分析揭示了与非酒精性脂肪变性向脂肪性肝炎疾病转变相关的早期特征。
Liver Res. 2022 Dec;6(4):238-250. doi: 10.1016/j.livres.2022.11.001. Epub 2022 Nov 22.
甲状腺激素受体-β 的激活可改善非酒精性脂肪性肝炎和肝纤维化小鼠模型的疾病活动度和代谢,而不依赖于体重。
Br J Pharmacol. 2021 Jun;178(12):2412-2423. doi: 10.1111/bph.15427. Epub 2021 Apr 6.
4
The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs.非酒精性脂肪性肝炎的发展在豚鼠中受到育种群依赖的变异的影响。
Sci Rep. 2021 Feb 3;11(1):2955. doi: 10.1038/s41598-021-82643-0.
5
Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver.肝特异性过表达 PPARγ 可保护小鼠免于 NASH,并增强罗格列酮在肝脏中的治疗效果。
Cell Mol Gastroenterol Hepatol. 2021;11(5):1291-1311. doi: 10.1016/j.jcmgh.2021.01.003. Epub 2021 Jan 11.
6
A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.反式脂肪酸替代物增强了胆碱缺乏、蛋氨酸降低、L-氨基酸定义、高脂肪饮食喂养的小鼠肝增生病变的发展。
Lipids Health Dis. 2020 Dec 14;19(1):251. doi: 10.1186/s12944-020-01423-3.
7
Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?非酒精性脂肪性肝炎纤维化的动物模型:它们能反映人类疾病吗?
Adv Nutr. 2020 Nov 16;11(6):1696-1711. doi: 10.1093/advances/nmaa081.
8
Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.两种非酒精性脂肪性肝病膳食小鼠模型引起的代谢和肝脏病理生物学差异。
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E863-E876. doi: 10.1152/ajpendo.00321.2020. Epub 2020 Sep 14.
9
Chronic ingestion of Primex-Z, compared with other common fat sources, drives worse liver injury and enhanced susceptibility to bacterial infections.与其他常见脂肪源相比,慢性摄入 Primex-Z 会导致更严重的肝损伤,并增强对细菌感染的易感性。
Nutrition. 2021 Jan;81:110938. doi: 10.1016/j.nut.2020.110938. Epub 2020 Jul 4.
10
Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis.非酒精性脂肪性肝炎的GAN饮食诱导肥胖小鼠模型的人体可翻译性。
BMC Gastroenterol. 2020 Jul 6;20(1):210. doi: 10.1186/s12876-020-01356-2.